Evidence map›Paper›PMID 33793091›Full record

ArticleCPT: pharmacometrics & systems pharmacology2021

A whole-body circulatory neutrophil model with application to predicting clinical neutropenia from in vitro studies.

Wenbo Chen, Britton Boras, Tae Sung, Wenyue Hu, Mary E Spilker, David Z D'Argenio

Open access · goldAbstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wenbo ChenDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California, USA.
Britton BorasPfizer Worldwide Research, Development and Medicine, San Diego, California, USA.
Tae SungPfizer Worldwide Research, Development and Medicine, San Diego, California, USA.
Wenyue HuPfizer Worldwide Research, Development and Medicine, San Diego, California, USA.
Mary E SpilkerPfizer Worldwide Research, Development and Medicine, San Diego, California, USA.
David Z D'ArgenioDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California, USA.
Pfizer (United States) · USUniversity of Southern California · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
TrainingP41EB001978 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KHOO, MICHAEL C K · 2003 to 2017
$18.1M
NCI ET-CTN with Phase i Emphasis at UPCIUM1CA186690 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD, Farshid Dayyani · 2014 to 2026
$9.1M
PITT-CAL ETCTN PK Resource LaboratoryU24CA247643 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TIMOTHY W SYNOLD, Raman Venkataramanan · 2020 to 2026
$3.6M
National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) P41-EB001978NCI NIH HHS P30 CA047904NCI NIH HHS U24 CA247643NIBIB NIH HHS P41 EB001978
6 · The paper itself

Abstract

A circulatory model of granulopoiesis and its regulation is presented that includes neutrophil trafficking in the lungs, liver, spleen, bone marrow, lymph nodes, and blood. In each organ, neutrophils undergo transendothelial migration from vascular to interstitial space, clearance due to apoptosis, and recycling via the lymphatic flow. The model includes cell cycling of progenitor cells in the bone marrow, granulocyte colony-stimulating factor (G-CSF) kinetics and its neutrophil regulatory action, as well as neutrophil margination in the blood. From previously reported studies,

Indexed as

Models, BiologicalAntineoplastic Combined Chemotherapy ProtocolsCarboplatinClinical Trials, Phase I as TopicFilgrastimGranulocyte Colony-Stimulating FactorHematologic AgentsHematopoiesisHumansLeukocyte CountNeutropeniaNeutrophilsPaclitaxelPolyethylene GlycolsCarboplatinFilgrastimGranulocyte Colony-Stimulating FactorHematologic AgentsPaclitaxelpegfilgrastimPolyethylene Glycols

Identifiers

PMID33793091
PMCPMC8302245
OpenAlexW3146323738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.